@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/uv/emedicinal-product-info/ClinicalUseDefinition/ac21a804-cafa-41ff-b644-a14c8003edeb> a fhir:ClinicalUseDefinition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "ac21a804-cafa-41ff-b644-a14c8003edeb"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi"^^xsd:anyURI ;
       fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ClinicalUseDefinition-warning-uv-epi>
     ] )
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ClinicalUseDefinition</b><a name=\"ac21a804-cafa-41ff-b644-a14c8003edeb\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ClinicalUseDefinition &quot;ac21a804-cafa-41ff-b644-a14c8003edeb&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ClinicalUseDefinition-warning-uv-epi.html\">ClinicalUseDefinition Warning (ePI)</a></p></div><p><b>identifier</b>: id: hypotension (use: OFFICIAL)</p><p><b>type</b>: warning</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-800a51a2-d81d-49a4-a4eb-f2417d301837.html\">MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837</a></p><h3>Warnings</h3><table class=\"grid\"><tr><td>-</td><td><b>Description</b></td></tr><tr><td>*</td><td>Intravascular volume depletion: symptomatic hypotension, especially after the first dose, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea or vomiting. Such conditions should be corrected before the administration of cava.</td></tr></table></div>"
  ] ; # 
  fhir:identifier ( [
     fhir:use [ fhir:v "official" ] ;
     fhir:system [ fhir:v "https://spor.ema.europa.eu/rmswi#"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "hypotension" ]
  ] ) ; # 
  fhir:type [ fhir:v "warning"] ; # 
  fhir:subject ( [
     fhir:link <http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837> ;
     fhir:reference [ fhir:v "MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837" ]
  ] ) ; # 
  fhir:warning [
     fhir:description [ fhir:v "Intravascular volume depletion: symptomatic hypotension, especially after the first dose, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea or vomiting. Such conditions should be corrected before the administration of cava." ]
  ] . # 

<http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/800a51a2-d81d-49a4-a4eb-f2417d301837> a fhir:uv .

# -------------------------------------------------------------------------------------

